Cargando…

SELDI-TOF mass spectrometry of High-Density Lipoprotein

BACKGROUND: High-Density Lipoprotein (HDL), one of the main plasma lipoproteins, serves as a docking station for proteins involved in inflammation, coagulation, and lipid metabolism. METHODS: To elucidate the protein composition of HDL, we employed SELDI-TOF mass spectrometry as a potential high-thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Levels, Johannes HM, Bleijlevens, Boris, Rezaee, Farhad, Aerts, Johannes MFG, Meijers, Joost CM
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2020459/
https://www.ncbi.nlm.nih.gov/pubmed/17822561
http://dx.doi.org/10.1186/1477-5956-5-15
_version_ 1782136599173136384
author Levels, Johannes HM
Bleijlevens, Boris
Rezaee, Farhad
Aerts, Johannes MFG
Meijers, Joost CM
author_facet Levels, Johannes HM
Bleijlevens, Boris
Rezaee, Farhad
Aerts, Johannes MFG
Meijers, Joost CM
author_sort Levels, Johannes HM
collection PubMed
description BACKGROUND: High-Density Lipoprotein (HDL), one of the main plasma lipoproteins, serves as a docking station for proteins involved in inflammation, coagulation, and lipid metabolism. METHODS: To elucidate the protein composition of HDL, we employed SELDI-TOF mass spectrometry as a potential high-throughput proteomic candidate for protein profiling of HDL. HDL derived from normolipemic individuals was captured on PS20 protein-chips using covalently bound antibodies against apo A-I or A-II. RESULTS: After optimisation, on-chip capture of HDL particles directly from plasma or from pre-purified HDL resulted in comparable fingerprints confirming specific capture of HDL. Depending on the capture antibody some differences in the fingerprint were observed. The most detailed fingerprint was observed up to 50 kDa; approximately 95 peaks were detected in the 3–50 kDa molecular mass range. Between 50 and 160 kDa, 27 more peaks were detected. CONCLUSION: Based on these results, SELDI-TOF MS may be a suitable high-throughput candidate for HDL protein profiling and marker search. This approach may be used to i) investigate the underlying mechanisms that lead to increased atherothrombotic risk and ii) to investigate the atherothrombotic state of an individual.
format Text
id pubmed-2020459
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-20204592007-10-13 SELDI-TOF mass spectrometry of High-Density Lipoprotein Levels, Johannes HM Bleijlevens, Boris Rezaee, Farhad Aerts, Johannes MFG Meijers, Joost CM Proteome Sci Methodology BACKGROUND: High-Density Lipoprotein (HDL), one of the main plasma lipoproteins, serves as a docking station for proteins involved in inflammation, coagulation, and lipid metabolism. METHODS: To elucidate the protein composition of HDL, we employed SELDI-TOF mass spectrometry as a potential high-throughput proteomic candidate for protein profiling of HDL. HDL derived from normolipemic individuals was captured on PS20 protein-chips using covalently bound antibodies against apo A-I or A-II. RESULTS: After optimisation, on-chip capture of HDL particles directly from plasma or from pre-purified HDL resulted in comparable fingerprints confirming specific capture of HDL. Depending on the capture antibody some differences in the fingerprint were observed. The most detailed fingerprint was observed up to 50 kDa; approximately 95 peaks were detected in the 3–50 kDa molecular mass range. Between 50 and 160 kDa, 27 more peaks were detected. CONCLUSION: Based on these results, SELDI-TOF MS may be a suitable high-throughput candidate for HDL protein profiling and marker search. This approach may be used to i) investigate the underlying mechanisms that lead to increased atherothrombotic risk and ii) to investigate the atherothrombotic state of an individual. BioMed Central 2007-09-06 /pmc/articles/PMC2020459/ /pubmed/17822561 http://dx.doi.org/10.1186/1477-5956-5-15 Text en Copyright © 2007 Levels et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Levels, Johannes HM
Bleijlevens, Boris
Rezaee, Farhad
Aerts, Johannes MFG
Meijers, Joost CM
SELDI-TOF mass spectrometry of High-Density Lipoprotein
title SELDI-TOF mass spectrometry of High-Density Lipoprotein
title_full SELDI-TOF mass spectrometry of High-Density Lipoprotein
title_fullStr SELDI-TOF mass spectrometry of High-Density Lipoprotein
title_full_unstemmed SELDI-TOF mass spectrometry of High-Density Lipoprotein
title_short SELDI-TOF mass spectrometry of High-Density Lipoprotein
title_sort seldi-tof mass spectrometry of high-density lipoprotein
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2020459/
https://www.ncbi.nlm.nih.gov/pubmed/17822561
http://dx.doi.org/10.1186/1477-5956-5-15
work_keys_str_mv AT levelsjohanneshm selditofmassspectrometryofhighdensitylipoprotein
AT bleijlevensboris selditofmassspectrometryofhighdensitylipoprotein
AT rezaeefarhad selditofmassspectrometryofhighdensitylipoprotein
AT aertsjohannesmfg selditofmassspectrometryofhighdensitylipoprotein
AT meijersjoostcm selditofmassspectrometryofhighdensitylipoprotein